Xospata Gilteritinib 40 Mg Tablet

Xospata is indicated as monotherapy for the treatment of adult patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation.

Form: Tablet
Strength: 40 mg
Usage/Application: Personal
Compostion: gilteritinib 40 mg
Storage Condition: normal room temp
Prescription/Non prescription: Prescription
japan: 221760.00 per strip of 21 tablet

Production Capacity: 5 box
Delivery Time: 4-5 days
Packaging Details: 1 box contain 4 strips of 21 tablets( (84 tablets) of Xospata 40 mg